theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hospital Medicine

Lymphoma   

Questions discussed in this category


How would you treat a young patient with symptomatic Rosai-Dorfman disease who has recurrent, life-threatening pericardial and pleural effusions?
CT scans show omental and pelvic disease.
1 Answer available

For inpatient treatment of lymphoma and ALL, can rituximab be delayed?
I.e., Can day 2 Rituximab (RCHOP) or day 6 Rituximab (DA-EPOCH, Hyper CVAD) be given? Or should only Day 1 Rituximab be used with chemoimmunotherapy i...
2 Answers available
76905438


Papers discussed in this category


Haematologica, 2020
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.

Nature, 2019-03
Efficacy of MEK inhibition in patients with histiocytic neoplasms.

Blood, 2018 May 02
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Leuk Lymphoma, 2019 Dec 26
Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease).

Related Topics in Hospital Medicine

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.